Randomized Controlled Pilot Trial of Extended-released Buprenorphine vs. Sublingual Buprenorphine-naloxone in Rural Settings
Latest Information Update: 06 May 2024
At a glance
- Drugs Buprenorphine (Primary) ; Buprenorphine/naloxone
- Indications Opioid-related disorders
- Focus Therapeutic Use
- Acronyms RXR
Most Recent Events
- 25 Apr 2024 Planned initiation date changed from 1 Jan 2024 to 1 Jul 2024.
- 07 Sep 2023 New trial record